| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 01/18/2006 | EP1616582A1 New dressing material promoting recovery of skin wound |
| 01/18/2006 | EP1616576A1 Specific nad(p)h oxidase inhibitor |
| 01/18/2006 | EP1616575A1 Method for treating inflammation |
| 01/18/2006 | EP1616571A2 Lysine containing peptides for treatment of heart disease |
| 01/18/2006 | EP1616563A2 Perivascular administration of anti-angiogenic factors for treating or preventing vascular diseases |
| 01/18/2006 | EP1615639A2 Targeted bone marrow protection agents |
| 01/18/2006 | EP1615630A1 Method for the treatment of diseases linked to an accumulation of triglycerides and cholesterol |
| 01/18/2006 | EP1501505B1 Use of (3-(2-ethylphenyl)-5-methoxyphenyl)-1h- 1,2,4 -triazole for the treatment of autoimmune diseases |
| 01/18/2006 | EP1470138B1 Mmp inhibitors |
| 01/18/2006 | EP1463799A4 Methods for the induction of professional and cytokine-producing regulatory cells |
| 01/18/2006 | EP1412338B1 1,3,5-triazine-2,4,6-triones, preparation and use as gonadotropin-releasing hormone receptor antagonists |
| 01/18/2006 | EP1404672B1 Tyrosine kinase inhibitors |
| 01/18/2006 | EP1286663B1 Encapsulating a toxic core within a non-toxic region in an oral dosage form |
| 01/18/2006 | EP1255733B1 Farnesyl transferase inhibitors |
| 01/18/2006 | EP1220852B1 Substituted diazepans |
| 01/18/2006 | EP1219595B1 O-anisamide derivatives |
| 01/18/2006 | EP1214064A4 Systems for agitated delivery of anti-infective compositions to treat disordered tissue such as cold sores |
| 01/18/2006 | EP1200320B9 Valve with a two-component seal |
| 01/18/2006 | EP1169475B1 Diagnosis of a person's risk for developing diabetic retinopathy |
| 01/18/2006 | EP0998274B1 Microdose therapy of vascular conditions by no donors |
| 01/18/2006 | EP0954308B1 Therapeutic treatment for cardiovascular diseases |
| 01/18/2006 | EP0828492B1 Medicaments for preventing intervention-associated stenosis following non-bypass, invasive interventions |
| 01/18/2006 | EP0735895B1 A method for preventing or controlling cataract |
| 01/18/2006 | CN1723211A Therapeutic agent for schizophrenia |
| 01/18/2006 | CN1723210A Fused furan compound |
| 01/18/2006 | CN1723209A Indol derivatives and their use as 5-HT ligands |
| 01/18/2006 | CN1723201A Blood-brain barrier disruption inhibitors |
| 01/18/2006 | CN1723197A Substituted 3-alkyl and 3-arylalkyl 1h-indol-1-yl acetic acid derivatives as inhibitors of plasminogen activator inhibitor-1 (PAI-1) |
| 01/18/2006 | CN1723196A Fluoropyrrolidines as dipeptidyl peptidase inhibitors |
| 01/18/2006 | CN1723059A Insulin receptor activators for the treatment of human body metabolic disorder resulting from treatment of HIV infection with HIV protease inhibitors |
| 01/18/2006 | CN1723021A Stable solid medicinal composition for oral administration. |
| 01/18/2006 | CN1723015A Fatigue reducing agent |
| 01/18/2006 | CN1721447A Modified peptides as therapeutic agents |
| 01/18/2006 | CN1721443A Human receptor proteins, related reagents and methods |
| 01/18/2006 | CN1721442A Proteins producing an altered immunogenic response and methods of making and using the same |
| 01/18/2006 | CN1721438A Human secreted protein hCGI-143 |
| 01/18/2006 | CN1721417A New pyrrolidine and thiazolidine compounds, a process for their preparation and pharmaceutical compositions containing them |
| 01/18/2006 | CN1721411A Benzimidazole derivatives as modulators IgE |
| 01/18/2006 | CN1721397A Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors |
| 01/18/2006 | CN1720995A The treatment of respiratory diseases |
| 01/18/2006 | CN1720912A Pharmaceutical compositions |
| 01/18/2006 | CN1237179C Targeted artificial gene delivery |
| 01/18/2006 | CN1237076C Polypeptide variants with altered effector function |
| 01/18/2006 | CN1237075C Low molecular weight peptide derivatives as inhibitors of laminin/nidogen interaction |
| 01/18/2006 | CN1237071C Conjugates of phytosterol or phytostanol with ascorbic acid and use thereof in treating or preventing cardiovascular disease |
| 01/18/2006 | CN1237062C Ortho-substituted anthranilic acid amides and their use as medicaments |
| 01/18/2006 | CN1237061C Chemokine receptor binding heterocyclic compounds |
| 01/18/2006 | CN1237060C Quinzolone derivatives as alpha IA/B adrenergic receptor antagonists |
| 01/18/2006 | CN1237055C 三唑衍生物 Triazole derivatives |
| 01/18/2006 | CN1237052C Ortho-substituted nitrogen-containing bisaryl compounds used as potassium channel inhibitors |
| 01/18/2006 | CN1236831C Compositions for protein delivery via the pulmonary route |
| 01/18/2006 | CN1236788C Medicine for curing upper respiratory tract infection and preparation method of its granule preparation |
| 01/18/2006 | CN1236773C Preparation for analgesia and anesthesia or treating drug dependence |
| 01/18/2006 | CN1236764C Method for preparing a composition |
| 01/18/2006 | CN1236763C Use of an epoxy-sterodal aldosterone antagonist for the treatment or prophylaxis of aldosterone-mediated pathogenic effects |
| 01/17/2006 | US6987184 Isothiazoloanthrones, isoxazoloanthrones, isoindolanthrones and derivatives thereof as JNK inhibitors and compositions and methods related |
| 01/17/2006 | US6987168 Tryptase inhibitor proteins derived from blood-feeding anthropod ectoparasites |
| 01/17/2006 | US6987129 Treating vaginismus, dyspareunia, interstitial cystitis, vulvodynia, vulvar vestibulitis, nonspecific urethritis, female sexual arousal orgasmic disorders or increasing vaginal lubrication, etc. |
| 01/17/2006 | US6987128 Compounds of the N-acylamino amide family, compositions comprising same, and uses |
| 01/17/2006 | US6987123 A substituted pyrrole-1-yl-alkyloxy-aryl-2-alkyloxypropanoate derivatives, antilipiemic agents, anticholesterol agents |
| 01/17/2006 | US6987120 Pharmaceutical compounds |
| 01/17/2006 | US6987119 Pharmaceutically acceptable salts thereof; their use as inhibitors of Raf kinases and pharmaceutical compositions containing them and anticancer agents |
| 01/17/2006 | US6987110 Such as 3-(1-(2-hydroxyethyl)-1H-indol-3-yl)-4-(1-(3-pyridinyl)-1H-indol-3-yl)-1H -pyrrole-2,5-dione |
| 01/17/2006 | US6987109 Solubilized topoisomerase poison agents |
| 01/17/2006 | US6987107 Method of treating incontinence |
| 01/17/2006 | US6987104 Peptidyl deformylase inhibitors used for inhibiting bacteria or preventing bacterial contamination of a cell culture medium |
| 01/17/2006 | US6987100 Pharmaceutical compositions for treating bone lesions in multiple myeloma |
| 01/17/2006 | US6987095 Fish feed with increased nucleotide content |
| 01/17/2006 | US6987088 Novel compounds which bind to the human erbB2 gene product (ErbB2, also known as HER2, or c-ErbB-2). In particular aspects, the invention provides for the treatment of disorders characterized by the overexpression of ErbB2 utilizing the |
| 01/17/2006 | US6987021 Methods and compositions for identifying morphogenic protein analogs using morphogenic protein responsive inhibitory elements |
| 01/17/2006 | US6987006 Genetically engineered erythropoietin for diagnosis, prevention and treatment of thrombis, cancer, neovascularization, inflammation and autoimmune diseases |
| 01/17/2006 | US6987005 Where the human SNORF33 receptor has the amino acid sequence SEQ ID NO: 6; encoded by ATCC deposited plasmids; activated by either tyramine, tryptamine, or beta -phenyl-ethylamine; vectors; cells; membranes; nervous system disorders |
| 01/17/2006 | US6987001 Methods and compositions using stearoyl-CoA desaturase to identify triglyceride reducing therapeutic agents |
| 01/17/2006 | US6986905 Pharmaceutical compositions for treating and saving and the method for the preparation thereof |
| 01/17/2006 | US6986346 Closure-cap and container as a two-chamber cartridge for nebulisers for producing aerosols and active substance formulations, suitable for storage |
| 01/17/2006 | CA2362394C Heteroaryl-substituted quinolin-2-one derivatives useful as anticancer agents |
| 01/17/2006 | CA2346171C Uses of 1-amino-3-(n,n-dimethylamino)-propylidene-1,1-bisphosphonic acid |
| 01/17/2006 | CA2334713C Therapeutic biaryl derivatives |
| 01/17/2006 | CA2229438C Mercaptoalkylpeptidyl compounds having an imidazole substituent and their use as inhibitors of matrix metalloproteinases (mmp) and/or tumour necrosis factor (tnf) |
| 01/17/2006 | CA2138930C Substituted benzenesulfonylureas and -thioureas, preparation processes and possible uses of pharmaceutical preparations based on these compounds |
| 01/17/2006 | CA2118812C 5-ht4 receptor antagonists |
| 01/17/2006 | CA2086425C Fibroblast growth factor receptors |
| 01/12/2006 | WO2006004173A1 Viral particle-like construct and method of forming the same under physiological conditions |
| 01/12/2006 | WO2006004115A1 Remedy for hyperactive bladder |
| 01/12/2006 | WO2006004105A1 Method of producing peptide mixture, method of producing fermented milk containing antihypertensive peptide and method of producing antihypertensive peptide preparation |
| 01/12/2006 | WO2006002453A2 Use of a deubiquitinating compound for enhancing the expression of membrane proteins on the cell surface |
| 01/12/2006 | WO2003089596A3 Novel prostate tumor-specific promoter |
| 01/12/2006 | US20060009527 Method of treating TRX mediated diseases |
| 01/12/2006 | US20060009526 Method of treating TRX mediated diseases |
| 01/12/2006 | US20060009525 Hydroxamic acids and acyl hydroxamines as NAALADase inhibitors |
| 01/12/2006 | US20060009521 Lipoxin analogs as novel inhibitors of angiogenesis |
| 01/12/2006 | US20060009517 Tricyclic inhibitors of poly(ADP-ribose) polymerases |
| 01/12/2006 | US20060009513 Nebivolol and its metabolites in combination with nitric oxide donors, compositions and methods of use |
| 01/12/2006 | US20060009503 Novel benzodifuranimidazoline and benzofuranimidazoline derivatives and their use for the treatment of glaucoma |
| 01/12/2006 | US20060009502 Medicine for prevention of and treatment for arteriosclerosis and hypertension |
| 01/12/2006 | US20060009495 Diary 1,2,4-triazole derivatives as a highly selective cyclooxygenase-2 inhibitor |
| 01/12/2006 | US20060009494 Compositions and methods for use against acne-induced inflammation and dermal matrix-degrading enzymes |
| 01/12/2006 | US20060009482 Screening method for identifying compounds that selectively induce interferon alpha |
| 01/12/2006 | US20060009475 Quinazolinone compounds in combined modalities for improved cancer treatment |
| 01/12/2006 | US20060009474 substituted amino pyrimidine derivatives useful in the treatment or prevention of viral infections, in particular against human immunodeficiency virus (HIV), which is the aetiological agent of acquired immune deficiency syndrome (AIDS) in humans |